ArticleFrontiers in immunology2023

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.

Yao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.